Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore

Cost-effectiveness of switching from biphasic human insulin (BHI) to biphasic insulin aspart 30 (BIAsp-30) in type 2 diabetes patients with suboptimal glycaemic control in Singapore

The aim of the analysis was to assess the long-term cost-effectiveness of switching from BHI to BIAsp-30 in type 2 diabetes patients with suboptimal glycaemic control in Singapore. Lifetime cost-effectiveness analysis was performed from both societal and healthcare perspectives using the published a...

Full description

Bibliographic Details
Main Authors: S Y Goh, S C Tan, L C Lim, B Chua, B Hunt
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:Journal of Diabetology
Subjects:
Biphasic insulin aspart
cost-effectiveness analysis
Singapore
Online Access:http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2015;volume=6;issue=1;spage=2;epage=2;aulast=Goh;type=0

Internet

http://www.journalofdiabetology.org/article.asp?issn=2078-7685;year=2015;volume=6;issue=1;spage=2;epage=2;aulast=Goh;type=0

Similar Items